Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells. [electronic resource]
Producer: 20200529Description: 110-120 p. digitalISSN:- 1559-0100
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Carcinoma -- drug therapy
- Cell Line, Tumor
- Drug Screening Assays, Antitumor
- Drug Synergism
- Histone Deacetylase Inhibitors -- administration & dosage
- Humans
- Quinazolines -- administration & dosage
- Reactive Oxygen Species -- metabolism
- Thyroid Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.